References
- Marx RE : Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws : a growing epidemic. J Oral Maxillofac Surg:61(9) : 1115, 2003 https://doi.org/10.1016/S0278-2391(03)00720-1
- Dimitrakopoulos I, Magopoulos C, Karakasis D : Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases. Int J Oral Maxillofac Surg 35(7) : 588, 2006 https://doi.org/10.1016/j.ijom.2006.02.022
- Ruggiero SL, Mehrotra B, Rosenberg TJ et al : Osteonecrosis of the jaws associated with the use of bisphosphonates : a review of 63 cases. J Oral Maxillofac Surg 62(5) : 527, 2004 https://doi.org/10.1016/j.joms.2004.02.004
- Bagan JV, Murillo J, Jimenez Y et al : Avascular jaw osteonecrosis in association with cancer chemotherapy : series of 10 cases. J Oral Pathol Med 34(2) : 120, 2005 https://doi.org/10.1111/j.1600-0714.2004.00269.x
- Ameican Association of Oral & Maxillofacial Surgeons : 2006 position paper on bisphosphonate-related osteonecrosis of the jaw. Available at http://www.aamos.org/, 2006
- Lin JH : Bisphosphonates : a review of their pharmacokinetic properties. Bone 18(2) : 75, 1996 https://doi.org/10.1016/8756-3282(95)00445-9
- Glowacki J : Bisphosphonates and bone. J at Harvard Med School 7 : 64, 2005
- van der Pluijm G, Vloedgraven H, van Beek E et al : Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro. J Clin Invest 98(3) : 698, 1996 https://doi.org/10.1172/JCI118841
- Haderslev KV, Tjellesen L, Sorensen HA et al : Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease. Gastroenterology 119(3) : 639, 2000 https://doi.org/10.1053/gast.2000.16518
- National Osteoporosis Foundation : America's Bone Health. Available at http://nof.org/advocacy/prevalence/ index.htm
- Groetz KA : Zahnarztliche Betruung on Patienten mit tumortherapeutischer Kopf-Hals-Bestrahlung. Paper presented at : Deutsche Gesellschaft f?r Zahn-Mund- und Kieferheilkunde : Germany, 2003
- Hansen T, Kunkel M, Weber A et al : Osteonecrosis of the jaws in patients treated with bisphosphonates-histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med 35(3) : 155, 2006 https://doi.org/10.1111/j.1600-0714.2006.00391.x
- Altundag K, Bulut N, Tezcan E et al : Tooth extraction : Is it inciting event or sequela of osteonecrosis of the jaws associated with intravenous bisphosphonates? J Oral Maxillofac Surg 65(1) : 154, 2007
- Groetz KA, Al-Nawas B : Persisting alveolar sockets-a radiologic symptom of BP-ONJ? J Oral Maxillofac Surg 64(10) : 1571, 2006
- Zavras AI, Zhu S : Bisphosphonates are associated with increased risk for jaw surgery in medical claims data : is it osteonecrosis? J Oral Maxillofac Surg 64(6) : 917, 2006 https://doi.org/10.1016/j.joms.2006.02.011
- Bamias A, Kastritis E, Bamia C et al : Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23(34) : 8580, 2005 https://doi.org/10.1200/JCO.2005.02.8670
- Durie BG, Katz M, Crowley J : Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353(1) : 99 : discussion 99-02, 2005 https://doi.org/10.1056/NEJM200507073530120
- Dimopoulos MA, Kastritis E, Anagnostopoulos A et al : Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates : evidence of increased risk after treatment with zoledronic acid. Haematologica 91(7) : 968, 2006
- American Dental Association : Dental management of patients receiving oral bisphosphonate therapy : expert panel recommendations. J Am Dent Assoc 137(8) : 1144, 2006 https://doi.org/10.14219/jada.archive.2006.0355
- Black DM, Delmas PD, Eastell R et al : Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356(18) : 1809, 2007 https://doi.org/10.1056/NEJMoa067312
- Walter C, Grotz KA, Kunkel M : Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis. Support Care Cancer 15(2) : 197, 2007 https://doi.org/10.1007/s00520-006-0120-z
- Ficarra G, Beninati F, Rubino I et al : Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment. J Clin Periodontol 32(11) : 1123, 2005 https://doi.org/10.1111/j.1600-051X.2005.00842.x
- American Association of Endodontists : Endodontic implications of bisphosphonate-associated osteonecrosis of the jaws. In : http://www.aae.org/NR/rdonlyres/4CF5373C- 690A-40D8-A542-2346F1996B4A/0/bisphosonatesstatement. pdf, editor : American Association of Endodontists, 2006
- Ruggiero SL, Fantasia J, Carlson E : Bisphosphonaterelated osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102(4) : 433, 2006 https://doi.org/10.1016/j.tripleo.2006.06.004
- Bone HG, Hosking D, Devogelaer JP et al : Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350(12) : 1189, 2004 https://doi.org/10.1056/NEJMoa030897
- Rosen HN, Moses AC, Garber J et al : Serum CTX : a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. Calcif Tissue Int 66(2) : 100, 2000 https://doi.org/10.1007/PL00005830